Daiichi Sankyo Europe

About Daiichi Sankyo Europe

Daiichi Sankyo Europe is a leading global pharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. With a strong commitment to improving patient outcomes, the company focuses on several therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases.

Founded in Japan, Daiichi Sankyo has expanded its operations across Europe, establishing a significant presence in the UK. The company prides itself on its robust pipeline of new drugs, which are developed through cutting-edge research and collaboration with healthcare professionals.

Core Activities:

• Research and Development: Investing heavily in R&D to discover new treatments that address unmet medical needs.
• Commercialization: Bringing innovative therapies to market to improve the quality of life for patients.
• Collaboration: Partnering with other organizations to enhance drug development and distribution.

Daiichi Sankyo Europe is also committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote health and well-being in communities. The company values diversity and inclusion, fostering a workplace culture that encourages creativity and innovation.

With a dedicated team of professionals, Daiichi Sankyo Europe aims to be at the forefront of medical advancements, striving to make a meaningful impact on global health.